These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 32708166

  • 21. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
    Xu Y, Lu W, Yang P, Peng W, Wang C, Li M, Li Y, Li G, Meng N, Lin H, Kan L, Wang S, Yang S, Yu L, Zhao Y.
    BMC Cancer; 2015 Jul 18; 15():525. PubMed ID: 26187637
    [Abstract] [Full Text] [Related]

  • 22. Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells.
    Prangsaengtong O, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K.
    Vasc Med; 2018 Jun 18; 23(3):201-211. PubMed ID: 29629844
    [Abstract] [Full Text] [Related]

  • 23. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT, Xu GC, Qi JW, Yang GL, Zhang K, Liu HL, Xu LX, Xiang R, Xiao G, Cao H, Wei Y, Zhang QZ, Li LY.
    J Pathol; 2015 Nov 18; 237(3):307-18. PubMed ID: 26096340
    [Abstract] [Full Text] [Related]

  • 24. Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation.
    Lee E, Rosca EV, Pandey NB, Popel AS.
    Int J Biochem Cell Biol; 2011 Dec 18; 43(12):1812-21. PubMed ID: 21920451
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.
    Wang X, Liu Z, Sun J, Song X, Bian M, Wang F, Yan F, Yu Z.
    FASEB J; 2021 Apr 18; 35(4):e21531. PubMed ID: 33769605
    [Abstract] [Full Text] [Related]

  • 26. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
    Holopainen T, Saharinen P, D'Amico G, Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M, Heloterä H, Tammela T, Benjamin LE, Ylä-Herttuala S, Leow CC, Koh GY, Alitalo K.
    J Natl Cancer Inst; 2012 Mar 21; 104(6):461-75. PubMed ID: 22343031
    [Abstract] [Full Text] [Related]

  • 27. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
    Hu J, Ye H, Fu A, Chen X, Wang Y, Chen X, Ye X, Xiao W, Duan X, Wei Y, Chen L.
    Int J Cancer; 2010 Nov 15; 127(10):2455-66. PubMed ID: 20162567
    [Abstract] [Full Text] [Related]

  • 28. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T.
    Pancreas; 2007 May 15; 34(4):444-51. PubMed ID: 17446844
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W, Fan YZ.
    Int J Oncol; 2012 Nov 15; 41(5):1762-72. PubMed ID: 22922710
    [Abstract] [Full Text] [Related]

  • 33. Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo.
    Rothley M, Schmid A, Thiele W, Schacht V, Plaumann D, Gartner M, Yektaoglu A, Bruyère F, Noël A, Giannis A, Sleeman JP.
    Int J Cancer; 2009 Jul 01; 125(1):34-42. PubMed ID: 19326439
    [Abstract] [Full Text] [Related]

  • 34. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
    Wang C, Xu S, Tian Y, Ju A, Hou Q, Liu J, Fu Y, Luo Y.
    Neoplasia; 2019 Apr 01; 21(4):413-427. PubMed ID: 30925417
    [Abstract] [Full Text] [Related]

  • 35. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
    Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, Maillard C, Munaut C, Sounni NE, Lambert V, Foidart JM, Rakic JM, Cataldo D, Noël A.
    Invest Ophthalmol Vis Sci; 2013 May 03; 54(5):3082-93. PubMed ID: 23580490
    [Abstract] [Full Text] [Related]

  • 36. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 May 03; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 37. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY, Hong SH, Shin M, Heo HR, Jang IH.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):733-8. PubMed ID: 27507214
    [Abstract] [Full Text] [Related]

  • 38. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
    Wang J, Lou P, Henkin J.
    J Cell Biochem; 2000 Apr 16; 77(3):465-73. PubMed ID: 10760954
    [Abstract] [Full Text] [Related]

  • 39. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N, Harris NC, Roufail S, Paquet-Fifield S, Ishaq M, Streltsov VA, Williams SP, Karnezis T, Stacker SA, Achen MG.
    J Biol Chem; 2016 Dec 30; 291(53):27265-27278. PubMed ID: 27852824
    [Abstract] [Full Text] [Related]

  • 40. Integrins in tumor angiogenesis and lymphangiogenesis.
    Foubert P, Varner JA.
    Methods Mol Biol; 2012 Dec 30; 757():471-86. PubMed ID: 21909928
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.